Fig. 1From: The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney diseaseFlowchart of CKD screening and treatment in the CKD health policy model. ACE, angiotensin-converting enzyme inhibitor; ACR, albumin-to-creatinine ratio; ARB, angiotensin receptor blockers; CKD, chronic kidney disease; GFR, glomerular filtration rateBack to article page